Skip to main content

and
  1. No Access

    Article

    Lymphocyte subsets as prognostic markers for cancer patients receiving immunomodulative therapy

    Immunogenic features of some malignancies have aroused interest in immunotherapy of cancer. Immunotherapy seems most effective in patients with a small tumour burden, and the focus of immunotherapy trials has,...

    Micaela Hernberg in Medical Oncology (1999)